Onglyza® (Saxagliptin) Receives Marketing Authorization in Europe for the Treatment of Type 2 Diabetes

被引：0
|
作者：
Idris, Iskandar [1 ]
机构：
[1] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England
来源：
DIABETES OBESITY & METABOLISM | 2010年 / 12卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [1] Saxagliptin (ONGLYZA™), receives positive opinion in Europe for the treatment of type 2 diabetes
    Idris, Iskandar
    DIABETES OBESITY & METABOLISM, 2009, 11 (09): : 912 - 912
  • [2] Onglyza get a European marketing authorization in the treatment of type 2 diabetes
    不详
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2010, 14 (1-2): : 42 - 42
  • [3] Saxagliptin (Onglyza) for Type 2 Diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2009, 51 (1324): : 85 - 86
  • [4] Saxagliptin (Onglyza) for Type 2 Diabetes Mellitus
    Whalen, Karen
    St Onge, Erin
    AMERICAN FAMILY PHYSICIAN, 2010, 81 (12) : 1483 - 1484
  • [5] Cost-effectiveness of saxagliptin (Onglyza®) in type 2 diabetes in Sweden
    Granstrom, Ola
    Bergenheim, Klas
    McEwan, Phil
    Sennfalt, Karin
    Henriksson, Martin
    PRIMARY CARE DIABETES, 2012, 6 (02) : 127 - 136
  • [6] COST-EFFECTIVENESS OF SAXAGLIPTIN (ONGLYZA®) IN TYPE 2 DIABETES IN SOUTH AFRICA
    Juarez-Garcia, A.
    Casalvolone, D.
    Qatami, L.
    Bergenheim, K.
    Donato, B. M. K.
    VALUE IN HEALTH, 2012, 15 (04) : A180 - A180
  • [7] Appraisal of Saxagliptin as Treatment of Type 2 Diabetes
    Mikhail, Nasser
    Cope, Dennis
    CURRENT DRUG THERAPY, 2010, 5 (02) : 111 - 117
  • [8] Saxagliptin: A New Drug for the Treatment of Type 2 Diabetes
    Thareja, Suresh
    Aggarwal, Saurabh
    Malla, Priyanka
    Haksar, Diksha
    Bhardwaj, Tilak Raj
    Kumar, Manoj
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (08) : 759 - 765
  • [9] SAXAGLIPTIN IN TYPE 2 DIABETES
    Billones, R.
    DRUGS OF TODAY, 2010, 46 (02) : 101 - 108
  • [10] Saxagliptin for type 2 diabetes
    Chacra, Antonio R.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2010, 3 : 325 - 335
12345